Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Main Authors: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1984
|
Registos relacionados
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Por: Bowen, D, et al.
Publicado em: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
Por: Wilcock, G, et al.
Publicado em: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
Por: Emma Barrett, et al.
Publicado em: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
Por: Hunter White, et al.
Publicado em: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
Por: Marianna Yanike, et al.
Publicado em: (2014-11-01)